Korro Bio
Massachusetts, United States
501-1000 Employees
Healthcare
•Tech
SEC Reporting Manager
Cambridge, --
MA Full time
Description
Korro Bio is a biotechnology company focused on developing novel gene editing technologies to advance precision medicine and transform the treatment of genetic diseases. Founded in 2018, Korro Bio's innovative approaches have the potential to revolutionize the field of genetic medicine and bring about new therapeutic solutions for patients worldwide.
Financials
Type
public
Annual Revenue
--
Market Cap
$225.6M+
Subscribe to Refer Me premium to get referred to this role at Korro Bio!
